Long-term results of a randomized controlled trial in childhood IgA nephropathy.

@article{Kamei2011LongtermRO,
  title={Long-term results of a randomized controlled trial in childhood IgA nephropathy.},
  author={Koichi Kamei and Koichi Nakanishi and Shuichi Ito and Mari Saito and Mayumi Sako and Kenji Ishikura and Hiroshi Hataya and Masataka Honda and Kazumoto Iijima and N. Yoshikawa},
  journal={Clinical journal of the American Society of Nephrology : CJASN},
  year={2011},
  volume={6 6},
  pages={1301-7}
}
BACKGROUND AND OBJECTIVES Children with IgA nephropathy showing diffuse (>80%) mesangial proliferation are at high risk for end-stage renal failure (ESRF). A previous controlled trial showed that combination therapy consisting of prednisolone, azathioprine, heparin-warfarin, and dipyridamole early in the course of disease reduces immunologic renal injury and prevents the progression of sclerosed glomeruli. The objective of this study was to evaluate the long-term effectiveness of combination… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 31 references

Combination therapy with mizoribine for severe childhood IgA nephropathy : A pilot study

  • K Nakanishi, N Yoshikawa
  • 2008

Similar Papers

Loading similar papers…